# A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults

> **NCT06867796** · PHASE1 · NOT_YET_RECRUITING · sponsor: **TrueLab Biopharmaceutical Co., Ltd** · enrollment: 48 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TL-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06867796
- **Lead sponsor:** TrueLab Biopharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06867796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06867796, "A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06867796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*